New pain cocktail aims to cut opioid use after brain surgery
NCT ID NCT06406829
First seen Feb 12, 2026 · Last updated Jun 20, 2026 · Updated 18 times
Summary
This study tests a combination of a sedative drug (dexmedetomidine) and a local numbing technique (scalp nerve block) to manage pain after brain tumor surgery. The goal is to reduce the need for strong opioid painkillers, which can have side effects. The trial will enroll 2000 adults undergoing planned brain tumor removal at a single hospital in China.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Dexmedetomidine and liposomal bupivacaine
What this could lead to
If successful, this could establish a standard pain management approach that reduces opioid use and speeds recovery after brain surgery.
What could go wrong
This is a single-center trial not yet recruiting, and the benefits seen in earlier studies may not hold in this larger, more diverse group. The interventions also carry risks like low heart rate or allergic reactions.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.